4//SEC Filing
Patel Sushil 4
Accession 0001610717-24-000394
CIK 0001628171other
Filed
Jul 9, 8:00 PM ET
Accepted
Jul 10, 4:36 PM ET
Size
8.4 KB
Accession
0001610717-24-000394
Insider Transaction Report
Form 4
Patel Sushil
Director
Transactions
- Sale
Common Stock
2024-07-09$44.00/sh−2,155$94,820→ 19,948 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-07-09−2,155→ 32,490 totalExercise: $16.80Exp: 2032-06-15→ Common Stock (2,155 underlying) - Exercise/Conversion
Common Stock
2024-07-09$16.80/sh+2,155$36,204→ 22,103 total
Footnotes (3)
- [F1]Transaction made pursuant to a 10b5-1 trading plan adopted by Sushil Patel on September 7, 2023.
- [F2]Includes 8,623 restricted stock units.
- [F3]The option becomes exercisable as it vests and the shares subject to the option vest with respect to 1/36 of the shares subject thereto on each monthly anniversary of June 16, 2022, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
Documents
Issuer
Revolution Medicines, Inc.
CIK 0001628171
Entity typeother
Related Parties
1- filerCIK 0001860609
Filing Metadata
- Form type
- 4
- Filed
- Jul 9, 8:00 PM ET
- Accepted
- Jul 10, 4:36 PM ET
- Size
- 8.4 KB